BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10643009)

  • 1. Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone.
    Zheng MH; Siu P; Papadimitriou JM; Wood DJ; Murch AR
    Pathology; 1999 Nov; 31(4):373-8. PubMed ID: 10643009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour.
    García JL; Robledo C; Lumbreras E; Flores T; Ramos L; Hernández JM
    Virchows Arch; 2006 Jan; 448(1):95-9. PubMed ID: 16220295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosome study on giant cell tumor of bone].
    Gou W; Feng C; Li H
    Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):97-101. PubMed ID: 7656714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone.
    Sawyer JR; Goosen LS; Binz RL; Swanson CM; Nicholas RW
    Cancer Genet Cytogenet; 2005 May; 159(1):32-6. PubMed ID: 15860354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations.
    Gorunova L; Vult von Steyern F; Storlazzi CT; Bjerkehagen B; Follerås G; Heim S; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2009 Jul; 48(7):583-602. PubMed ID: 19396867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and oncogenesis in giant cell tumor of bone.
    Schwartz HS; Juliao SF; Sciadini MF; Miller LK; Butler MG
    Cancer; 1995 Mar; 75(5):1094-9. PubMed ID: 7850706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histogenesis of giant cell tumors].
    Wuelling M; Engels C; Jesse N; Werner M; Kaiser E; Delling G
    Pathologe; 2002 Sep; 23(5):332-9. PubMed ID: 12376858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
    Huang L; Xu J; Wood DJ; Zheng MH
    Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic analyses on giant cell tumor of bone].
    Zhu QS; Qiu JS
    Zhonghua Bing Li Xue Za Zhi; 1994; 23(3):162-5. PubMed ID: 7954956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of microsatellite instability in giant cell tumor of bone.
    Scheiner M; Hedges L; Schwartz HS; Butler MG
    Cancer Genet Cytogenet; 1996 May; 88(1):35-8. PubMed ID: 8630976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group.
    Sciot R; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Tallini G; Van den Berghe H; Vanni R; Willén H
    Mod Pathol; 2000 Nov; 13(11):1206-10. PubMed ID: 11106078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts.
    Zheng MH; Robbins P; Xu J; Huang L; Wood DJ; Papadimitriou JM
    Histol Histopathol; 2001 Jan; 16(1):297-307. PubMed ID: 11193206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
    Rao VH; Singh RK; Delimont DC; Finnell RH; Bridge JA; Neff JR; Garvin BP; Pickering DL; Sanger WG; Buehler BA; Schaefer GB
    Int J Oncol; 1999 Feb; 14(2):291-300. PubMed ID: 9917505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of transforming growth factor beta in giant cell tumor of bone.
    Butler MG; Dahir GA; Schwartz HS
    Cancer Genet Cytogenet; 1993 Apr; 66(2):108-12. PubMed ID: 8500096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in giant cell tumors of bone.
    Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
    Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic analysis of the mononuclear cell component of giant cell tumors of bone.
    Montero O; Salle MT; Guevara R; Olivera P; Maldonado V; Meléndez-Zajgla J
    Cancer Genet Cytogenet; 2003 Oct; 146(2):170-2. PubMed ID: 14553953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere reduction in giant cell tumor of bone and with aging.
    Schwartz HS; Dahir GA; Butler MG
    Cancer Genet Cytogenet; 1993 Dec; 71(2):132-8. PubMed ID: 8281516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bone morphogenetic proteins in giant cell tumor of bone.
    Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
    Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal anomalies exclusive of telomeric associations in giant cell tumor of bone.
    McComb EN; Johansson SL; Neff JR; Nelson M; Bridge JA
    Cancer Genet Cytogenet; 1996 Jun; 88(2):163-6. PubMed ID: 8640728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.